HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maite Sainz de la Maza Selected Research

Cyclosporine (Ciclosporin)

11/2018Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study.
11/2017One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maite Sainz de la Maza Research Topics

Disease

2Keratitis
11/2018 - 11/2017
2Dry Eye Syndromes (Dry Eye Syndrome)
11/2018 - 11/2017

Drug/Important Bio-Agent (IBA)

2EmulsionsIBA
11/2018 - 11/2017
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2018 - 11/2017